Epigenetics Is Implicated in the Basis of Gender Incongruence: An Epigenome-Wide Association Analysis

The main objective was to carry out a global DNA methylation analysis in a population with gender incongruence before gender-affirming hormone treatment (GAHT), in comparison to a cisgender population. A global CpG (cytosine-phosphate-guanine) methylation analysis was performed on blood from 16 tran...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in neuroscience Vol. 15; p. 701017
Main Authors: Ramirez, Karla, Fernández, Rosa, Collet, Sarah, Kiyar, Meltem, Delgado-Zayas, Enrique, Gómez-Gil, Esther, Van Den Eynde, Tibbert, T'Sjoen, Guy, Guillamon, Antonio, Mueller, Sven C, Pásaro, Eduardo
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 19-08-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The main objective was to carry out a global DNA methylation analysis in a population with gender incongruence before gender-affirming hormone treatment (GAHT), in comparison to a cisgender population. A global CpG (cytosine-phosphate-guanine) methylation analysis was performed on blood from 16 transgender people before GAHT vs. 16 cisgender people using the Illumina© Infinium Human Methylation 850k BeadChip, after bisulfite conversion. Changes in the DNA methylome in cisgender vs. transgender populations were analyzed with the Partek Genomics Suite program by a 2-way ANOVA test comparing populations by group and their sex assigned at birth. The principal components analysis (PCA) showed that both populations (cis and trans) differ in the degree of global CpG methylation prior to GAHT. The 2-way ANOVA test showed 71,515 CpGs that passed the criterion FDR < 0.05. Subsequently, in male assigned at birth population we found 87 CpGs that passed both criteria (FDR < 0.05; fold change ≥ ± 2) of which 22 were located in islands. The most significant CpGs were related to genes: , and . Regarding the female assigned at birth populations, we found 2 CpGs that passed both criteria (FDR < 0.05; fold change ≥ ± 2), but none were located in islands. One of these CpGs, related to the MPPED2 gene, is shared by both, trans men and trans women. The enrichment analysis showed that these genes are involved in functions such as negative regulation of gene expression (GO:0010629), central nervous system development (GO:0007417), brain development (GO:0007420), ribonucleotide binding (GO:0032553), and RNA binding (GO:0003723), among others. It is the first time that a global CpG methylation analysis has been carried out in a population with gender incongruence before GAHT. A prospective study before/during GAHT would provide a better understanding of the influence of epigenetics in this process. The main finding of this study is that the cis and trans populations have different global CpG methylation profiles prior to GAHT. Therefore, our results suggest that epigenetics may be involved in the etiology of gender incongruence.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Arturo Ortega, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico; Daniela Grassi, Autonomous University of Madrid, Spain
This article was submitted to Neuroendocrine Science, a section of the journal Frontiers in Neuroscience
Edited by: Mitsuhiro Kawata, Kyoto Prefectural University of Medicine, Japan
These authors have contributed equally to this work and share first authorship
ISSN:1662-4548
1662-453X
1662-453X
DOI:10.3389/fnins.2021.701017